DoD Gulf War Illness Investigator Initiated Research Award | Apply Online

Opportunity Summary:

The DoD Gulf War Illness Investigator Initiated Research Award (IIRA) is a Department of the Army USAMRAA funding mechanism under the Gulf War Illness Research Program (GWIRP) that supports investigator-driven research aimed at improving how Gulf War Illness (GWI) is defined, diagnosed, and biologically understood. The program is built around the reality that GWI is a complex, multi-symptom condition affecting Gulf War veterans, and it prioritizes studies that can clarify what is happening biologically in affected veterans and how to objectively distinguish ill veterans from healthy controls. Since the mechanism began in FY2006, 156 applications were received and 42 were recommended for funding, showing it is competitive but established.

The core purpose of the IIRA is to encourage basic through clinical research that advances objective measurement and mechanistic insight. Projects are expected to focus on identifying objective indicators of illness (often framed as biomarkers), defining measurable abnormalities associated with GWI, and uncovering underlying pathobiology that could point toward treatment targets. The scope includes research that investigates the chronic, long-term effects of neurotoxic exposures at doses comparable to what troops may have encountered during the Gulf War, reflecting the program's interest in exposure-related mechanisms and lasting biological change. While treatment development is not the primary focus in the sense of running human clinical trials, the award explicitly supports early work that could enable later therapeutic testing by helping establish proof of principle, clarify targets, or generate the kinds of data needed to justify larger follow-on studies.

The announcement highlights several topical areas of particular interest, largely centered on systems that may plausibly connect diverse symptoms into coherent biological pathways. These include central nervous system structure and function (with special emphasis on glial biology such as astrocytes and microglia), neuroinflammatory processes in the central nervous system, autonomic nervous system function, neuroendocrine measures, immune parameters and indicators of chronic infection, gastrointestinal symptoms, and a range of molecular profiling approaches such as genetic, genomic, proteomic, and metabolic characteristics. Respiratory symptoms and sexual dysfunction are also specifically called out, underscoring that the program is open to studying the full spectrum of GWI symptomatology rather than a narrow subset.

A notable feature of the IIRA is its emphasis on novel ideas and its flexibility regarding preliminary data. Applicants are not required to provide preliminary results, although they may include them if helpful. Importantly, any preliminary data used to support an application do not need to come from prior GWI-focused work, which lowers the barrier for investigators entering the field from adjacent areas (for example, researchers working on other chronic multi-symptom illnesses or related neuroimmune conditions). At the same time, proposals without preliminary data are expected to be grounded in a strong scientific rationale, potentially drawing on clinical observations, established biology, or discoveries made in related illnesses that can be directly evaluated in Gulf War veterans. Across all approaches, the key expectation is that the project remains clearly centered on ill Gulf War veterans and that the principal investigator explicitly explains the likely impact of the work on understanding, defining, or diagnosing GWI.

For studies involving human participants, the mechanism allows clinical research but places a firm restriction against clinical trials. In this context, a clinical trial is defined as prospective enrollment of human subjects in which an intervention (such as a drug, device, biologic, procedure, rehabilitation approach, behavioral intervention, or similar) is tested for measurable outcomes related to safety, effectiveness, or efficacy. That means the IIRA is appropriate for observational, mechanistic, and other non-interventional studies, including retrospective analyses and other designs that do not prospectively assign an intervention. Investigators who want to run an interventional clinical trial are directed instead to other GWIRP mechanisms such as the Innovative Treatment Evaluation Award or the Clinical Trial Award.

The program also provides specific expectations for how applicants define the GWI population they intend to study. If proposing clinical research, applicants must identify a published case definition they will use, and that definition must reflect the multi-symptom nature of GWI. For applicants using animal models, the guidance is to focus on long-term and latent effects of toxicant exposures so that the model better reflects the chronic condition experienced by current patients rather than only acute exposure effects. The announcement references the 2008 Research Advisory Committee on Gulf War Veterans' Illnesses report as a useful resource for case definitions and prior treatment research context, signaling that proposals should be informed by established discussions in the field.

From an administrative standpoint, this opportunity (Funding Opportunity Number W81XWH-13-GWIRP-IIRA) was posted May 14, 2013, with an original and final closing date of September 18, 2013, and an archive date of October 18, 2013. It is categorized as discretionary funding and uses either a cooperative agreement or grant funding instrument under CFDA 12.420 (Military Medical Research and Development). The estimated total funding listed is $2,880,000 with an expected three awards, and there is no cost sharing or matching requirement. Eligibility is listed as unrestricted, meaning it is broadly open to different entity types, subject to any clarifications in the full announcement. For access issues, the announcement directs applicants to the CDMRP Help Desk at 301-682-5507.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: STD Laboratory based Surveillance and Gonococcal Isolate Surveillance Project (GISP)

Previous opportunity: Cooperative Ecosystem Studies Unit, Colorado Plateau CESU

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 13 GWIRP IIRA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 13 GWIRP IIRA) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 13 GWIRP IIRA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.